Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

PHIOPhio Pharmaceuticals Corp.

Nasdaq · CIK 0001533040
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts360

Identity from submissions API

NamePhio Pharmaceuticals Corp.
CIK0001533040
TickersPHIO
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2834 Pharmaceutical Preparations
EIN453215903
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone(508) 767-3861
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • RXi Pharmaceuticals Corp (2011-10-25T00:00:00.000Z → 2018-11-14T00:00:00.000Z)
Business address
411 SWEDELAND ROAD
SUITE 23-1080
KING OF PRUSSIA
PA
19406
PA
Mailing address
411 SWEDELAND ROAD
SUITE 23-1080
KING OF PRUSSIA
PA
19406
PA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

900 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-20 8-K FORM 8-K 3.01 0001437749-26-037895 001-36304 261579301 34 158408 1 1
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001649553-26-000139 005-86901 261558783 34 12017
2026-11-16 4 xslF345X06/ownership.xml 0001683168-26-008786 6577
2026-11-12 4 xslF345X06/ownership.xml 0001683168-26-008544 7651
2026-11-10 4 xslF345X06/ownership.xml 0001683168-26-008471 4990
2026-11-10 4 xslF345X06/ownership.xml 0001683168-26-008469 5089
2026-11-05 10-Q FORM 10-Q 0001437749-26-035280 001-36304 261527512 34 3895087 1 1
2026-11-05 8-K FORM 8-K 2.02,9.01 0001437749-26-035277 001-36304 261527467 34 264563 1 1
2026-10-13 8-K FORM 8-K 8.01,9.01 0001437749-26-032505 001-36304 261454873 34 182263 1 1
2026-09-30 4 xslF345X06/ownership.xml 0001683168-26-007499 6527
2026-09-29 4 xslF345X06/ownership.xml 0001683168-26-007481 5208
2026-09-29 4 xslF345X06/ownership.xml 0001683168-26-007483 5289
2026-09-29 4 xslF345X06/ownership.xml 0001683168-26-007482 5189
2026-09-28 S-8 FORM S-8 0001437749-26-031367 333-299168 261417761 33 201401 1 1
2026-09-28 8-K FORM 8-K 5.02,5.07,9.01 0001437749-26-031337 001-36304 261417186 34 196856 1 1
2026-09-25 4 xslF345X06/ownership.xml 0001683168-26-007432 5043
2026-09-23 4 xslF345X06/ownership.xml 0001683168-26-007321 5090
2026-09-16 4 xslF345X06/ownership.xml 0001683168-26-007192 5042
2026-09-15 4 xslF345X06/ownership.xml 0001683168-26-007158 5290
2026-09-15 4 xslF345X06/ownership.xml 0001683168-26-007159 5372
2026-09-14 8-K FORM 8-K 8.01,9.01 0001437749-26-030236 001-36304 261375963 34 183558 1 1
2026-08-20 4 xslF345X06/ownership.xml 0001683168-26-006620 4800
2026-08-19 4 xslF345X06/ownership.xml 0001683168-26-006592 5089
2026-08-14 ARS ANNUAL REPORT 0001683168-26-006475 001-36304 261281679 34 1233798
2026-08-14 DEFA14A ADDITIONAL DEFINITIVE PROXY SOLICITING MATERIALS 0001683168-26-006474 001-36304 261281639 34 1096357
2026-08-14 DEF 14A FORM DEF 14A 0001437749-26-027997 001-36304 261281136 34 2062501 1 1
2026-08-06 8-K FORM 8-K 2.02,9.01 0001437749-26-026275 001-36304 261249327 34 264421 1 1
2026-08-06 10-Q FORM 10-Q 0001437749-26-026271 001-36304 261249212 34 3751205 1 1
2026-07-30 3 xslF345X06/ownership.xml 0001683168-26-005842 14833
2026-07-21 8-K FORM 8-K 5.02,8.01,9.01 0001437749-26-023916 001-36304 261188144 34 184984 1 1
2026-06-29 4 xslF345X06/ownership.xml 0001683168-26-005164 5089
2026-05-07 10-Q FORM 10-Q 0001437749-26-015604 001-36304 26953911 34 3498254 1 1
2026-05-07 8-K FORM 8-K 2.02,9.01 0001437749-26-015590 001-36304 26953565 34 243978 1 1
2026-04-08 8-K FORM 8-K 1.01,9.01 0001437749-26-011761 001-36304 26848312 34 423402 1 1
2026-04-08 424B5 PROSPECTUS SUPPLEMENT 0001683168-26-002750 333-279557 26848263 33 389576
2026-03-30 8-K FORM 8-K 8.01 0001437749-26-010164 001-36304 26809958 34 175037 1 1
2026-03-05 10-K FORM 10-K 0001437749-26-007078 001-36304 26726374 34 6454256 1 1
2026-03-05 8-K FORM 8-K 2.02,9.01 0001437749-26-007071 001-36304 26726193 34 234260 1 1
2026-02-18 8-K FORM 8-K 5.02 0001437749-26-004542 001-36304 26648066 34 172236 1 1
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001649553-26-000030 005-86901 26639917 34 11819
2026-02-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001213900-26-016522 005-86901 26634029 34 11627
2026-02-10 8-K FORM 8-K 8.01,9.01 0001437749-26-003575 001-36304 26613467 34 176290 1 1
2026-02-06 4 xslF345X05/ownership.xml 0001683168-26-000813 5247
2026-02-06 4 xslF345X05/ownership.xml 0001683168-26-000811 5243
2026-02-06 4 xslF345X05/ownership.xml 0001683168-26-000809 5097
2026-02-06 4 xslF345X05/ownership.xml 0001683168-26-000807 5068
2026-02-06 4 xslF345X05/ownership.xml 0001683168-26-000805 5273
2026-02-06 4 xslF345X05/ownership.xml 0001683168-26-000803 5151
2026-01-20 8-K FORM 8-K 8.01,9.01 0001437749-26-001500 001-36304 26541368 34 176024 1 1
2026-01-02 4 xslF345X05/ownership.xml 0001683168-26-000013 4950
2025-12-29 4 xslF345X05/ownership.xml 0001683168-25-009349 4951
2025-12-23 8-K FORM 8-K 8.01,9.01 0001437749-25-038607 001-36304 251595060 34 170850 1 1
2025-12-11 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001493152-25-027252 005-86901 251565383 34 7339
2025-12-04 424B3 FORM 424B3 0001683168-25-008889 333-291667 251549362 33 140501
2025-12-03 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-003514 333-291667 251548162 33 1883
2025-12-01 CORRESP filename1.htm 0001683168-25-008768 6956
2025-11-25 8-K FORM 8-K 8.01,9.01 0001437749-25-036329 001-36304 251521334 34 177185 1 1
2025-11-24 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001493152-25-024820 005-86901 251512924 34 7345
2025-11-24 4 xslF345X05/ownership.xml 0001683168-25-008639 4951
2025-11-20 S-3 REGISTRATION STATEMENT 0001683168-25-008586 333-291667 251503091 33 594581 1 1
2025-11-19 4 xslF345X05/ownership.xml 0001683168-25-008537 4951
2025-11-13 10-Q FORM 10-Q 0001437749-25-034857 001-36304 251478944 34 4756925 1 1
2025-11-13 8-K FORM 8-K 2.02,9.01 0001437749-25-034848 001-36304 251478838 34 250367 1 1
2025-11-12 D xslFormDX01/primary_doc.xml 06b 0001123292-25-000633 021-563765 251473556 33 11608
2025-11-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001493152-25-021629 005-86901 251468321 34 7377
2025-11-10 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001649553-25-000206 005-86901 251467799 34 16193
2025-11-07 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001213900-25-107723 005-86901 251463725 34 13053
2025-11-06 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001493152-25-021091 005-86901 251459378 34 7306
2025-11-06 8-K FORM 8-K 1.01,3.02,8.01,9.01 0001437749-25-033600 001-36304 251458383 34 498539 1 1
2025-11-03 8-K FORM 8-K 8.01,9.01 0001437749-25-032662 001-36304 251442170 34 185067 1 1
2025-10-31 8-K FORM 8-K 5.02,8.01,9.01 0001437749-25-032512 001-36304 251438579 34 177754 1 1
2025-09-15 4/A xslF345X05/ownership.xml 0001683168-25-006986 5770
2025-09-15 8-K FORM 8-K 5.02,5.07 0001683168-25-006985 001-36304 251314299 34 216666 1 1
2025-09-15 4 xslF345X05/ownership.xml 0001683168-25-006961 17624
2025-09-15 4 xslF345X05/ownership.xml 0001683168-25-006959 17782
2025-09-15 4 xslF345X05/ownership.xml 0001683168-25-006958 17779
2025-09-15 4 xslF345X05/ownership.xml 0001683168-25-006957 17774
2025-09-15 4 xslF345X05/ownership.xml 0001683168-25-006956 5076
2025-09-15 4 xslF345X05/ownership.xml 0001683168-25-006955 17812
2025-09-15 4 xslF345X05/ownership.xml 0001683168-25-006954 19468
2025-09-11 S-8 REGISTRATION STATEMENT 0001683168-25-006846 333-290186 251307423 33 338265 1 1
2025-09-03 8-K CURRENT REPORT 8.01,9.01 0001683168-25-006641 001-36304 251287790 34 215512 1 1
2025-08-28 DEFA14A ADDITIONAL DEFINITIVE PROXY SOLICITING MATERIALS 0001683168-25-006511 001-36304 251273202 34 16093
2025-08-27 424B3 PROSPECTUS 0001683168-25-006496 333-289621 251266313 33 131037
2025-08-22 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-002730 333-289621 251247809 33 1883
2025-08-21 CORRESP filename1.htm 0001683168-25-006371 6458
2025-08-21 UPLOAD filename1.pdf 0000000000-25-008902 333-289621 40239
2025-08-15 S-3 REGISTRATION STATEMENT 0001683168-25-006179 333-289621 251221595 33 606774 1 1
2025-08-14 10-Q FORM 10-Q FOR JUN 2025 0001683168-25-006174 001-36304 251220408 34 5198673 1 1
2025-08-14 8-K CURRENT REPORT 2.02,9.01 0001683168-25-006171 001-36304 251219672 34 248426 1 1
2025-08-07 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001641172-25-022581 005-86901 251193893 34 7400
2025-08-04 D xslFormDX01/primary_doc.xml 06b 0001123292-25-000336 021-553575 251178840 33 11300
2025-07-30 8-K FORM 8-K 1.01,3.02,8.01,9.01 0001683168-25-005523 001-36304 251166945 34 598462 1 1
2025-07-30 ARS FORM ARS 0001683168-25-005522 001-36304 251166918 34 1434001
2025-07-30 DEFA14A ADDITIONAL DEFINITIVE PROXY MATERIALS 0001683168-25-005521 001-36304 251166911 34 844134
2025-07-30 DEF 14A DEFINITIVE PROXY 0001683168-25-005520 001-36304 251166895 34 1468980 1 1
2025-07-25 8-K CURRENT REPORT 8.01,9.01 0001683168-25-005392 001-36304 251150979 34 232763 1 1
2025-07-07 8-K CURRENT REPORT 8.01 0001683168-25-004948 001-36304 251107945 34 197606 1 1
2025-06-26 8-K CURRENT REPORT 8.01,9.01 0001683168-25-004759 001-36304 251074855 34 217863 1 1
2025-06-18 3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-011890 22798
2025-06-12 8-K FORM 8-K 5.02,9.01 0001683168-25-004421 001-36304 251041665 34 307404 1 1
2025-06-11 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-011424 4794
2025-06-11 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-011423 4673
2025-06-10 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-011326 4794
2025-05-23 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-010155 6430
2025-05-21 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-009985 5250
2025-05-15 10-Q FORM 10-Q 0001683168-25-003719 001-36304 25954321 34 3089549 1 1
2025-05-15 8-K CURRENT REPORT 2.02,9.01 0001683168-25-003715 001-36304 25954173 34 253291 1 1
2025-05-07 8-K FORM 8-K 8.01,9.01 0001683168-25-003237 001-36304 25921566 34 219952 1 1
2025-04-22 8-K FORM 8-K 4.01,9.01 0001683168-25-002725 001-36304 25857707 34 206260 1 1
2025-04-09 8-K CURRENT REPORT 8.01,9.01 0001683168-25-002355 001-36304 25823885 34 222620 1 1
2025-03-31 10-K FORM 10-K FOR DEC 2024 0001683168-25-002134 001-36304 25794120 34 6089095 1 1
2025-03-31 8-K CURRENT REPORT 2.02,9.01 0001683168-25-002131 001-36304 25793459 34 259082 1 1
2025-03-04 3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-004347 11798
2025-02-20 8-K FORM 8-K 5.02,8.01,9.01 0001683168-25-001137 001-36304 25644859 34 221755 1 1
2025-02-07 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001649553-25-000039 005-86901 25601786 34 11869
2025-01-29 424B3 PROSPECTUS 0001683168-25-000577 333-284381 25569306 33 992813
2025-01-28 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-000224 333-284381 25566448 33 1885
2025-01-28 D xslFormDX01/primary_doc.xml 06b 0001123292-25-000031 021-536530 25564397 33 11522
2025-01-28 D xslFormDX01/primary_doc.xml 06b 0001123292-25-000029 021-536528 25564276 33 11522
2025-01-28 D xslFormDX01/primary_doc.xml 06b 0001123292-25-000027 021-536524 25564176 33 11408
2025-01-27 CORRESP filename1.htm 0001683168-25-000550 6921
2025-01-24 UPLOAD filename1.pdf 0000000000-25-000806 333-284381 40272
2025-01-23 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001493152-25-003376 005-86901 25549913 34 7453
2025-01-21 S-1 S-1 0001683168-25-000460 333-284381 25542998 33 4354086 1 1
2025-01-17 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001213900-25-004657 005-86901 25539245 34 24777
2025-01-17 8-K CURRENT REPORT 1.01,3.02,8.01,9.01 0001683168-25-000426 001-36304 25538660 34 871249 1 1
2025-01-17 424B5 FORM 424B5 0001683168-25-000413 333-279557 25537042 33 408313
2025-01-15 8-K CURRENT REPORT 1.01,3.02,8.01,9.01 0001683168-25-000384 001-36304 25532944 34 871362 1 1
2025-01-15 424B5 PROSPECTUS 0001683168-25-000356 333-279557 25531204 33 402328
2025-01-14 8-K CURRENT REPORT 1.01,8.01,9.01 0001683168-25-000347 001-36304 25530241 34 864577 1 1
2025-01-14 424B5 PROSPECTUS 0001683168-25-000324 333-279557 25528736 33 398093
2025-01-13 8-K CURRENT REPORT 8.01,9.01 0001683168-25-000274 001-36304 25525322 34 221318 1 1
2025-01-07 D xslFormDX01/primary_doc.xml 06b 0001123292-25-000005 021-534479 25514937 33 11461
2025-01-03 D xslFormDX01/primary_doc.xml 06b 0001123292-25-000003 021-534199 25507033 33 11429
2024-12-27 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001213900-24-113155 005-86901 241586261 34 19306
2024-12-26 8-K FORM 8-K 1.01,3.02,8.01,9.01 0001683168-24-008984 001-36304 241581059 34 867907 1 1
2024-12-26 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-24-131663 005-86901 241580508 34 20037
2024-12-23 424B5 FORM 424B5 0001683168-24-008939 333-279557 241573609 33 388587
2024-12-20 8-K CURRENT REPORT 1.01,3.02,8.01,9.01 0001683168-24-008884 001-36304 241567922 34 865735 1 1
2024-12-20 424B5 PROSPECTUS SUPPLEMENT 0001683168-24-008867 333-279557 241565160 33 383167
2024-12-19 8-K FORM 8-K 8.01,9.01 0001683168-24-008833 001-36304 241561069 34 219890 1 1
2024-11-14 10-Q FORM 10-Q FOR SEPT 2024 0001683168-24-008120 001-36304 241463715 34 3460737 1 1
2024-11-14 8-K FORM 8-K 2.02,9.01 0001683168-24-008118 001-36304 241463681 34 263315 1 1
2024-11-13 SC 13G/A AMENDMENT NO. 5 TO SCHEDULE 13G 0001213900-24-097266 005-86901 241452128 34 53846
2024-11-07 8-K FORM 8-K 8.01,9.01 0001683168-24-007713 001-36304 241433727 34 227256 1 1
2024-09-13 4 xslF345X05/ownership.xml 0001683168-24-006377 5119
2024-09-13 4 xslF345X05/ownership.xml 0001683168-24-006375 5074
2024-09-13 4 xslF345X05/ownership.xml 0001683168-24-006373 5149
2024-09-12 4 xslF345X05/ownership.xml 0001683168-24-006336 5074
2024-09-12 4 xslF345X05/ownership.xml 0001683168-24-006334 5071
2024-09-12 4 xslF345X05/ownership.xml 0001683168-24-006332 5111
2024-08-15 4 xslF345X05/ownership.xml 0001683168-24-005773 5190
2024-08-14 8-K CURRENT REPORT 2.02,9.01 0001683168-24-005707 001-36304 241209257 34 254509 1 1
2024-08-14 10-Q FORM 10-Q FOR JUNE 2024 0001683168-24-005706 001-36304 241209002 34 3454763 1 1
2024-08-09 3 xslF345X02/ownership.xml 0001683168-24-005394 3168
2024-08-05 424B3 FORM 424B3 0001683168-24-005259 333-281052 241173141 33 176063
2024-08-01 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2024-08-01 16:00:00 9999999995-24-002365 333-281052 241168693 33 1886
2024-08-01 8-K CURRENT REPORT 5.02,9.01 0001683168-24-005194 001-36304 241164414 34 302929 1 1
2024-07-30 CORRESP filename1.htm 0001683168-24-005128 7434
2024-07-29 UPLOAD filename1.pdf 0000000000-24-008615 333-281052 40313
2024-07-26 S-1 REGISTRATION STATEMENT 0001683168-24-005092 333-281052 241147381 33 586470 1 1
2024-07-24 8-K FORM 8-K 8.01 0001683168-24-005049 001-36304 241138445 34 198495 1 1
2024-07-24 D xslFormDX01/primary_doc.xml 06b 0001123292-24-000200 021-519563 241135646 33 10768
2024-07-12 8-K FORM 8-K 1.01,3.02,8.01,9.01 0001683168-24-004800 001-36304 241114839 34 593242 1 1
2024-07-05 8-K FORM 8-K 1.02,8.01,9.01 0001683168-24-004683 001-36304 241101687 34 211930 1 1
2024-07-02 8-K FORM 8-K 3.03,5.03,8.01,9.01 0001683168-24-004619 001-36304 241096677 34 245404 1 1
2024-07-01 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-07-01 16:00:00 9999999995-24-002034 333-279557 241092806 33 1886
2024-06-27 CORRESP filename1.htm 0001683168-24-004524 6981
2024-06-21 8-K FORM 8-K 5.02,5.07,9.01 0001683168-24-004417 001-36304 241061092 34 397361 1 1
2024-06-11 4 xslF345X05/ownership.xml 0001683168-24-004126 4948
2024-06-10 4 xslF345X05/ownership.xml 0001683168-24-004089 4949
2024-05-28 8-K CURRENT REPORT 8.01,9.01 0001683168-24-003849 001-36304 24992824 34 218076 1 1
2024-05-24 UPLOAD filename1.pdf 0000000000-24-006053 333-279557 40460
2024-05-20 S-3 FORM S-3 0001683168-24-003698 333-279557 24965533 33 692787 1 1
2024-05-20 RW FORM RW 0001683168-24-003696 333-279511 24965479 NE 8209
2024-05-17 S-1 S-3 0001683168-24-003624 333-279511 24960629 33 693548 1 1
2024-05-17 424B5 PROSPECTUS 0001683168-24-003600 333-256100 24957874 33 370294
2024-05-17 8-K FORM 8-K 1.01,8.01,9.01 0001683168-24-003598 001-36304 24957855 34 449468 1 1
2024-05-09 8-K CURRENT REPORT 2.02,9.01 0001683168-24-003178 001-36304 24931996 34 245514 1 1
2024-05-09 10-Q FORM 10-Q FOR 3/31/24 0001683168-24-003175 001-36304 24931976 34 2772052 1 1
2024-05-08 DEFA14A FORM DEFA14A 0001683168-24-003114 001-36304 24927338 34 480503
2024-05-08 DEF 14A DEFINITIVE PROXY STATEMENT 0001683168-24-003113 001-36304 24927300 34 2497273
2024-05-08 ARS ANNUAL REPORT TO SECURITY HOLDERS 0001683168-24-003112 001-36304 24927271 34 1439146
2024-04-22 PRE 14A PRELIMINARY PROXY STATEMENT 0001683168-24-002589 001-36304 24861930 34 916682
2024-04-02 8-K CURRENT REPORT 2.02,9.01 0001683168-24-002050 001-36304 24812219 34 252185 1 1
2024-04-01 10-K 10-K FOR 12/31/23 0001683168-24-002021 001-36304 24809882 34 5231271 1 1
2024-03-05 4 xslF345X05/ownership.xml 0001683168-24-001324 5172
2024-02-27 4 xslF345X05/ownership.xml 0001683168-24-001216 4932
2024-02-22 4 xslF345X05/ownership.xml 0001683168-24-001134 5224
2024-02-20 4 xslF345X05/ownership.xml 0001683168-24-001086 6717
2024-02-06 SC 13G/A AMENDMENT NO. 4 TO SCHEDULE 13G 0001213900-24-010340 005-86901 24598796 34 56133
2024-01-26 8-K FORM 8-K 3.01 0001683168-24-000489 001-36304 24568734 34 199342 1 1
2023-12-28 424B3 424B3 0001683168-23-009119 333-276146 231519670 33 156916
2023-12-27 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2023-12-27 16:00:00 9999999995-23-003764 333-276146 231519256 33 1874
2023-12-22 CORRESP filename1.htm 0001683168-23-009065 6730
2023-12-21 UPLOAD filename1.pdf 0000000000-23-013985 40405
2023-12-19 S-1 REGISTRATION STATEMENT 0001683168-23-008964 333-276146 231498126 33 577921 1 1
2023-12-19 D xslFormDX01/primary_doc.xml 06b 0001123292-23-000208 021-500104 231496472 33 10538
2023-12-08 8-K CURRENT REPORT 1.01,3.02,8.01,9.01 0001683168-23-008732 001-36304 231476209 34 573892 1 1
2023-11-09 8-K CURRENT REPORT 2.02,8.01,9.01 0001683168-23-007815 001-36304 231393281 34 262108 1 1
2023-11-09 10-Q FORM 10-Q FOR SEPT 2023 0001683168-23-007809 001-36304 231393104 34 3259302 1 1
2023-10-03 4 FORM 4 SUBMISSION 0001209191-23-051706 5198
2023-09-29 S-8 FORM S-8 0001683168-23-006837 333-274787 231296168 33 84029
2023-08-21 8-K FORM 8-K 8.01,9.01 0001683168-23-005923 001-36304 231187331 34 221949 1 1
2023-08-10 8-K CURRENT REPORT 2.02,9.01 0001683168-23-005515 001-36304 231160219 34 251160 1 1
2023-08-10 10-Q QUARTERLY REPORT 0001683168-23-005514 001-36304 231160051 34 2956814 1 1
2023-07-26 8-K FORM 8-K 5.02,5.07,9.01 0001683168-23-005094 001-36304 231113991 34 394471 1 1
2023-07-05 4 FORM 4 SUBMISSION 0001209191-23-041254 6491
2023-06-20 424B3 424B3 0001683168-23-004247 333-272526 231023736 33 168143
2023-06-16 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2023-06-16 17:00:00 9999999995-23-001782 333-272526 231023187 33 1825
2023-06-15 4 FORM 4 SUBMISSION 0001209191-23-037408 4790
2023-06-14 CORRESP filename1.htm 0001683168-23-004114 6379
2023-06-14 UPLOAD filename1.pdf 0000000000-23-006396 40374
2023-06-13 D xslFormDX01/primary_doc.xml 06b 0001683168-23-004102 021-484103 231011740 33 11598
2023-06-09 ARS ANNUAL REPORT TO SECURITY HOLDERS 0001683168-23-004047 001-36304 231005837 34 1649397
2023-06-09 DEFA14A PROXY CARD 0001683168-23-004046 001-36304 231005817 34 456161
2023-06-09 DEF 14A DEFINITIVE PROXY STATEMENT 0001683168-23-004045 001-36304 231005761 34 3610435
2023-06-08 S-1 REGISTRATION STATEMENT 0001683168-23-004016 333-272526 231002749 33 582689 1 1
2023-06-02 8-K FORM 8-K 1.01,3.02,8.01,9.01 0001683168-23-003863 001-36304 23989295 34 1463739 1 1
2023-06-01 424B5 424B5 0001683168-23-003815 333-256100 23985493 33 369152
2023-05-24 8-K CURRENT REPORT 8.01,9.01 0001683168-23-003671 001-36304 23950608 34 221452 1 1
2023-05-16 8-K CURRENT REPORT 8.01,9.01 0001683168-23-003433 001-36304 23925579 34 218302 1 1
2023-05-11 8-K FORM 8-K 2.02,9.01 0001683168-23-003214 001-36304 23912036 34 251313 1 1
2023-05-11 10-Q FORM 10-Q 0001683168-23-003213 001-36304 23912014 34 3021899 1 1
2023-05-10 424B3 PROSPECTUS 0001683168-23-003127 333-271521 23906977 33 141178
2023-05-09 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2023-05-09 16:00:00 9999999995-23-001352 333-271521 23904117 33 1824
2023-05-05 CORRESP filename1.htm 0001683168-23-002979 6786
2023-05-05 UPLOAD filename1.pdf 0000000000-23-004688 40358
2023-05-02 D xslFormDX01/primary_doc.xml 06b 0001683168-23-002852 021-480606 23879197 33 11639
2023-04-28 S-1 S-1 0001683168-23-002765 333-271521 23868127 33 312308
2023-04-20 8-K FORM 8-K 8.01,9.01 0001683168-23-002559 001-36304 23834007 34 204162 1 1
2023-04-20 424B3 PROSPECTUS SUPPLEMENT 0001683168-23-002554 333-224799 23832785 33 13074
2023-04-20 424B3 FORM 424(B)(3) 0001683168-23-002552 333-252588 23832783 33 13050
2023-04-20 424B3 424(B)(3) 0001683168-23-002550 333-234032 23832753 33 13250
2023-04-20 424B3 FORM 424(B)(3) 0001683168-23-002548 333-238204 23832746 33 13124
2023-04-20 424B3 FORM 424(B)(3) 0001683168-23-002546 333-227173 23832744 33 13845
2023-04-20 424B3 FORM 424(B)(3) 0001683168-23-002544 333-239779 23832737 33 13010
2023-04-20 8-K CURRENT REPORT 1.01,3.02,9.01 0001683168-23-002542 001-36304 23832727 34 939524 1 1
2023-04-19 424B5 FORM 424(B)(5) 0001683168-23-002531 333-256100 23830662 33 390188
2023-04-18 8-K CURRENT REPORT 8.01,9.01 0001683168-23-002493 001-36304 23825509 34 220673 1 1
2023-04-17 8-K CURRENT REPORT 8.01,9.01 0001683168-23-002488 001-36304 23824843 34 220984 1 1
2023-03-22 8-K CURRENT REPORT 2.02,9.01 0001683168-23-001679 001-36304 23753631 34 257138 1 1
2023-03-22 10-K FORM 10-K 0001683168-23-001678 001-36304 23753592 34 5621497 1 1
2023-03-10 8-K FORM 8-K 8.01 0001683168-23-001424 001-36304 23724652 34 197856 1 1
2023-03-03 4 FORM 4 SUBMISSION 0001209191-23-015880 5113
2023-02-22 4 FORM 4 SUBMISSION 0001209191-23-011942 5148
2023-02-22 4 FORM 4 SUBMISSION 0001209191-23-011937 5143
2023-02-22 4 FORM 4 SUBMISSION 0001209191-23-011932 5139
2023-02-22 4 FORM 4 SUBMISSION 0001209191-23-011926 5125
2023-02-22 4 FORM 4 SUBMISSION 0001209191-23-011920 5175
2023-02-22 4 FORM 4 SUBMISSION 0001209191-23-011911 5014
2023-02-22 4 FORM 4 SUBMISSION 0001209191-23-011909 5282
2023-02-22 8-K FORM 8-K 5.02,9.01 0001683168-23-001075 001-36304 23650538 34 342233 1 1
2023-02-17 4 FORM 4 SUBMISSION 0001209191-23-010876 5275
2023-02-13 8-K FORM 8-K 8.01 0001683168-23-000781 001-36304 23614691 34 197999 1 1
2023-02-08 SC 13G/A AMENDMENT NO. 3 TO SCHEDULE 13G 0001213900-23-009116 005-86901 23596947 34 67812
2023-01-25 8-K FORM 8-K 3.03,5.03,8.01,9.01 0001683168-23-000307 001-36304 23549904 34 247833 1 1
2023-01-06 8-K FORM 8-K 5.07,7.01,9.01 0001683168-23-000098 001-36304 23515770 34 1571720 1 1
2022-12-21 8-K FORM 8-K 8.01,9.01 0001683168-22-008584 001-36304 221478770 34 224049 1 1
2022-12-15 4 FORM 4 SUBMISSION 0001209191-22-061471 4882
2022-12-08 4 FORM 4 SUBMISSION 0001209191-22-060358 4882
2022-12-06 4 FORM 4 SUBMISSION 0001209191-22-060009 4882
2022-12-05 4 FORM 4 SUBMISSION 0001209191-22-059702 5228
2022-12-02 DEFA14A ADDITIONAL DEFINITIVE PROXY SOLICITING MATERIALS 0001683168-22-008171 001-36304 221442847 34 15615
2022-11-30 DEF 14A DEFINITIVE PROXY 0001683168-22-008106 001-36304 221436086 34 481062
2022-11-29 4 FORM 4 SUBMISSION 0001209191-22-058942 6465
2022-11-28 4 FORM 4 SUBMISSION 0001209191-22-058862 4761
2022-11-23 D xslFormDX01/primary_doc.xml 06b 0001567619-22-020839 021-465775 221416268 33 9715
2022-11-16 4 FORM 4 SUBMISSION 0001209191-22-057333 5252
2022-11-16 8-K CURRENT REPORT 1.01,3.02,3.03,5.03,9.01 0001683168-22-007821 001-36304 221395968 34 285934 1 1
2022-11-16 PRE 14A PRELIMINARY PROXY STATEMENT 0001683168-22-007820 001-36304 221395876 34 481302
2022-11-10 8-K FORM 8-K 2.02,9.01 0001683168-22-007530 001-36304 221378385 34 265074 1 1
2022-11-10 10-Q FORM 10-Q 0001683168-22-007528 001-36304 221378298 34 3211128 1 1
2022-10-03 4 FORM 4 SUBMISSION 0001209191-22-051984 5034
2022-09-29 8-K FORM 8-K 5.02,9.01 0001683168-22-006665 001-36304 221277778 34 215127 1 1
2022-09-26 4 FORM 4 SUBMISSION 0001209191-22-051302 4860
2022-08-26 8-K CURRENT REPORT 3.01 0001683168-22-006086 001-36304 221205202 34 200554 1 1
2022-08-12 8-K FORM 8-K 5.07 0001683168-22-005634 001-36304 221160268 34 207032 1 1
2022-08-11 8-K CURRENT REPORT 2.02,9.01 0001683168-22-005566 001-36304 221156767 34 262330 1 1
2022-08-11 10-Q FORM 10-Q 0001683168-22-005565 001-36304 221156631 34 3161078 1 1
2022-06-30 DEFA14A DEFA14A 0001683168-22-004729 001-36304 221058442 34 688272
2022-06-30 DEF 14A DEFINITIVE PROXY 0001683168-22-004728 001-36304 221058376 34 563207
2022-05-12 8-K CURRENT REPORT 2.02,9.01 0001683168-22-003517 001-36304 22918782 34 251001 1 1
2022-05-12 10-Q FORM 10-Q 0001683168-22-003516 001-36304 22918648 34 3064214 1 1
2022-05-10 8-K FORM 8-K 5.02 0001683168-22-003391 001-36304 22910801 34 202612 1 1
2022-05-02 8-K FORM 8-K 5.01,5.03,9.01 0001683168-22-003069 001-36304 22879397 34 283919 1 1
2022-04-29 3 FORM 3 SUBMISSION 0001209191-22-026308 6315
2022-04-29 10-K/A FORM 10-K AMENDMENT 1 0001683168-22-003052 001-36304 22876583 34 220850
2022-03-22 8-K CURRENT REPORT 2.02,9.01 0001683168-22-001835 001-36304 22760541 34 253107 1 1
2022-03-22 10-K FORM 10-K 0001683168-22-001833 001-36304 22760477 34 5538775 1 1
2022-03-03 4 FORM 4 SUBMISSION 0001209191-22-015894 5116
2022-03-03 4 FORM 4 SUBMISSION 0001209191-22-015893 5113
2022-03-03 8-K CURRENT REPORT 3.01,9.01 0001683168-22-001424 001-36304 22710266 34 260873 1 1
2022-02-16 4 FORM 4 SUBMISSION 0001209191-22-010405 4987
2022-02-16 4 FORM 4 SUBMISSION 0001209191-22-010402 5016
2022-02-16 4 FORM 4 SUBMISSION 0001209191-22-010396 4982
2022-02-16 4 FORM 4 SUBMISSION 0001209191-22-010391 4978
2022-02-16 4 FORM 4 SUBMISSION 0001209191-22-010388 4976
2022-02-16 4 FORM 4 SUBMISSION 0001209191-22-010384 5014
2022-02-16 4 FORM 4 SUBMISSION 0001209191-22-010377 4964
2022-02-16 4 FORM 4 SUBMISSION 0001209191-22-010372 5033
2022-02-11 SC 13G/A AMEDMENT NO. 2 TO SCHEDULE 13G 0001213900-22-006700 005-86901 22616762 34 66942
2022-01-20 SC 13G/A PHIO PHARMACEUTICALS CORP. 0000902664-22-000373 005-86901 22540986 34 77749
2021-12-21 25-NSE xslF25X02/primary_doc.xml 0001354457-21-001484 001-36304 211509344 34 3054
2021-11-10 8-K FORM 8-K 2.02,9.01 0001683168-21-005423 001-36304 211397347 34 260908 1 1
2021-11-10 10-Q FORM 10-Q 0001683168-21-005420 001-36304 211397171 34 3824659 1 1
2021-08-17 4 FORM 4 SUBMISSION 0001209191-21-051759 4820
2021-08-12 8-K FORM 8-K 2.02,9.01 0001683168-21-003479 001-36304 211168645 34 259444 1 1
2021-08-12 10-Q FORM 10-Q 0001683168-21-003476 001-36304 211168515 34 3655332 1 1
2021-06-21 8-K FORM 8-K 5.07 0001683168-21-002649 001-36304 211031367 34 27584
2021-05-21 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2021-05-21 17:00:00 9999999995-21-002069 333-256100 21950974 33 1824
2021-05-19 CORRESP filename1.htm 0001683168-21-002113 6102
2021-05-19 UPLOAD filename1.pdf 0000000000-21-006323 40344
2021-05-13 8-K CURRENT REPORT 2.02,9.01 0001683168-21-001972 001-36304 21920673 34 70315
2021-05-13 10-Q FORM 10-Q 0001683168-21-001971 001-36304 21920661 34 2547811 1
2021-05-13 S-3 FORM S-3 0001683168-21-001968 333-256100 21920643 33 1566924
2021-05-06 DEFA14A DEFA14A 0001683168-21-001801 001-36304 21898749 34 346430
2021-04-30 DEF 14A DEF 14A 0001683168-21-001666 001-36304 21879290 34 604235
2021-03-25 8-K FORM 8-K 2.02,9.01 0001683168-21-001063 001-36304 21773529 34 75307
2021-03-25 10-K FORM 10-K 0001683168-21-001062 001-36304 21773520 34 3758647 1
2021-03-05 4 FORM 4 SUBMISSION 0001209191-21-018054 4819
2021-03-03 4 FORM 4 SUBMISSION 0001209191-21-017573 5127
2021-03-03 4 FORM 4 SUBMISSION 0001209191-21-017575 5063
2021-03-03 4 FORM 4 SUBMISSION 0001209191-21-017574 5069
2021-03-03 4 FORM 4 SUBMISSION 0001209191-21-017571 5074
2021-03-03 4 FORM 4 SUBMISSION 0001209191-21-017570 5120
2021-03-03 4 FORM 4 SUBMISSION 0001209191-21-017572 6606
2021-03-03 4 FORM 4 SUBMISSION 0001209191-21-017569 6596
2021-03-03 4 FORM 4 SUBMISSION 0001209191-21-017568 5178
2021-02-19 SC 13G PHIO PHARMACEUTICALS CORP. 0000902664-21-001514 005-86901 21652974 34 83977
2021-02-17 8-K FORM 8-K 1.01,3.02,9.01 0001683168-21-000600 001-36304 21644934 34 348801
2021-02-17 424B5 PROSPECTUS SUPPLEMENT 0001683168-21-000593 333-224031 21642767 33 358454
2021-02-16 SC 13G/A SC 13G/A 0001104659-21-023252 005-86901 21633771 34 59960
2021-02-16 D xslFormDX01/primary_doc.xml 06b 0001683168-21-000554 021-389435 21630175 33 13404
2021-02-09 424B2 PROSPECTUS SUPPLEMENT 0001683168-21-000437 333-252588 21603967 33 176134
2021-02-08 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2021-02-08 17:00:00 9999999995-21-000508 333-252588 21603768 33 1824
2021-02-05 CORRESP filename1.htm 0001683168-21-000398 5976
2021-02-04 S-3/A FORM S-3 AMENDMENT 1 0001683168-21-000395 333-252588 21592362 33 60458
2021-02-02 UPLOAD filename1.pdf 0000000000-21-001304 40341
2021-01-29 S-3 FORM S-3 REGISTRATION STATEMENT 0001683168-21-000315 333-252588 21572476 33 280927
2021-01-29 SC 13G/A AMENDMENT NO. 1 TO SCHEDULE 13G 0001213900-21-005111 005-86901 21567968 34 62262
2021-01-25 8-K FORM 8-K 1.01,3.02,9.01 0001683168-21-000249 001-36304 21550738 34 617969
2021-01-05 SC 13G/A SABBY 13G-A PHIO 1.05.21 0001535610-21-000011 005-86901 21503916 34 13401
2020-12-23 S-8 REGISTRATION STATEMENT 0001683168-20-004444 333-251670 201413527 33 258970
2020-11-10 8-K FORM 8-K 2.02,9.01 0001683168-20-003810 001-36304 201301963 34 75481
2020-11-10 10-Q QUARTERLY REPORT 0001683168-20-003809 001-36304 201301952 34 2477985 1
2020-10-13 8-K FORM 8-K 5.03,5.07,9.01 0001683168-20-003428 001-36304 201236666 34 91801
2020-08-28 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001683168-20-002904 001-36304 201148610 34 397765
2020-08-28 DEF 14A DEFINITIVE PROXY STATEMENT 0001683168-20-002903 001-36304 201148591 34 827700
2020-08-19 4 FORM 4 SUBMISSION 0001209191-20-047533 4820
2020-08-12 8-K FORM 8-K 2.02,9.01 0001683168-20-002650 001-36304 201096118 34 84273
2020-08-12 10-Q FORM 10-Q 0001683168-20-002649 001-36304 201096078 34 2554388 1
2020-07-20 424B3 424B3 0001683168-20-002318 333-239779 201037000 33 131500
2020-07-17 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2020-07-17 16:30:00 9999999995-20-001854 333-239779 201034921 33 1825
2020-07-15 UPLOAD filename1.pdf 0000000000-20-006458 40257
2020-07-15 CORRESP filename1.htm 0001683168-20-002284 6028
2020-07-09 S-1 FORM S-1 0001683168-20-002231 333-239779 201021166 33 264122
2020-06-02 424B3 PROSPECTUS 0001683168-20-001823 333-238204 20937895 33 133657
2020-06-01 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2020-06-01 16:30:00 9999999995-20-001301 333-238204 20935504 33 1824
2020-05-29 CORRESP filename1.htm 0001683168-20-001784 6150
2020-05-28 CORRESP filename1.htm 0001683168-20-001773 40929
2020-05-28 S-1/A AMENDMENT NO. 1 0001683168-20-001772 333-238204 20922312 33 251280
2020-05-21 UPLOAD filename1.pdf 0000000000-20-004567 45479
2020-05-12 S-1 FORM S-1 0001683168-20-001524 333-238204 20870016 33 264328
2020-05-12 8-K FORM 8-K 2.01,9.01 0001683168-20-001520 001-36304 20869583 34 74481
2020-05-12 10-Q FORM 10-Q FOR MARCH 31, 2020 0001683168-20-001519 001-36304 20869582 34 2299597 1
2020-04-14 D xslFormDX01/primary_doc.xml 06b 0001683168-20-001189 021-364970 20791942 33 13370
2020-04-09 SC 13G SC 13G 0001104659-20-044916 005-86901 20783441 34 105478
2020-04-08 SC 13G d8515987_13-g.htm 0000919574-20-002821 005-86901 20782346 34 117551
2020-04-02 8-K CURRENT REPORT 1.01,3.02,9.01 0001683168-20-001071 001-36304 20769955 34 600749
2020-04-01 424B5 PROSPECTUS SUPPLEMENT 0001683168-20-001063 333-224031 20766097 33 341399
2020-03-26 8-K FORM 8-K 2.02,9.01 0001683168-20-000971 001-36304 20747085 34 83210
2020-03-26 10-K FORM 10-K 0001683168-20-000969 001-36304 20747078 34 3642724 1
2020-03-12 8-K FORM 8-K 8.01,9.01 0001683168-20-000783 001-36304 20708939 34 37421
2020-03-03 4 FORM 4 SUBMISSION 0001209191-20-015801 5252
2020-02-28 S-8 FORM S-8 REGISTRATION STATEMENT 0001683168-20-000630 333-236784 20672244 33 51869
2020-02-24 D xslFormDX01/primary_doc.xml 06b 0001683168-20-000567 021-361241 20645698 33 13282
2020-02-14 SC 13G d8477433_13g.htm 0000919574-20-001615 005-86901 20618298 34 107901
2020-02-13 8-K FORM 8-K 1.01,8.01,9.01 0001683168-20-000483 001-36304 20612172 34 739638
2020-02-13 SC 13G SCHEDULE 13G 0001213900-20-003677 005-86901 20612143 34 121412
2020-02-12 424B4 424B4 0001683168-20-000451 333-234032 20605551 33 325639
2020-02-11 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2020-02-11 09:00:00 9999999995-20-000314 333-234032 20599558 33 1824
2020-02-11 SC 13G SABBY 13G PHIO 2.11.20 0001535610-20-000069 005-86901 20595569 34 13393
2020-02-10 SC 13G/A SC 13G/A 0001104659-20-013419 005-86901 20591623 34 88056
2020-02-10 8-K FORM 8-K 8.01 0001683168-20-000420 001-36304 20589590 34 19344
2020-02-07 CORRESP filename1.htm 0001683168-20-000392 10985
2020-02-07 CORRESP filename1.htm 0001683168-20-000391 6317
2020-02-07 S-1/A AMENDMENT NO. 2 TO REGISTRATION STATEMENT 0001683168-20-000390 333-234032 20586820 33 505213
2020-02-06 8-K FORM 8-K 1.01,3.02,9.01 0001683168-20-000378 001-36304 20583495 34 397843
2020-02-06 424B5 PROSPECTUS SUPPLEMENT 0001683168-20-000372 333-224031 20580728 33 353903
2020-01-31 S-1/A AMENDMENT #1 TO REGISTRATION STATEMENT 0001683168-20-000317 333-234032 20566172 33 1103060
2020-01-22 SC 13G/A SABBY 13G-A PHIO 1.22.20 0001535610-20-000054 005-86901 20538111 34 13449
2020-01-14 8-K FORM 8-K 3.03,5.03,8.01,9.01 0001683168-20-000141 001-36304 20526528 34 51515
2020-01-10 8-K FORM 8-K 5.07 0001683168-20-000082 001-36304 20522007 34 18877
2019-12-18 8-K FORM 8-K 8.01 0001683168-19-004008 001-36304 191291263 34 20139
2019-12-13 DEFA14A ADDITIONAL PROXY MATERIALS 0001683168-19-003967 001-36304 191284908 34 31198
2019-12-13 DEFA14A NOTICE AND PROXY STATEMENT 0001683168-19-003961 001-36304 191283451 34 34062
2019-12-06 8-K/A FORM 8-K AMENDMENT 3.01,9.01 0001683168-19-003908 001-36304 191273796 34 40114
2019-11-22 DEF 14A DEFINITIVE PROXY 0001683168-19-003804 001-36304 191242596 34 335482

Latest XBRL company facts

One latest value per concept from companyfacts (360 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 11.95M 2026-11-03 2026 Q3 10-Q 2026-11-05 0001437749-26-035280
dei EntityPublicFloat Entity Public Float USD 11.20M 2025-06-30 2025 FY 10-K 2026-03-05 0001437749-26-007078
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 564,494 2025-01-01 2025-12-31 DEF 14A 2026-08-14 0001437749-26-027997
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 599,704 2025-01-01 2025-12-31 DEF 14A 2026-08-14 0001437749-26-027997
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 885,952 2025-01-01 2025-12-31 DEF 14A 2026-08-14 0001437749-26-027997
ecd PeoTotalCompAmt PeoTotalCompAmt USD 1.16M 2025-01-01 2025-12-31 DEF 14A 2026-08-14 0001437749-26-027997
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 19.33 2025-01-01 2025-12-31 DEF 14A 2026-08-14 0001437749-26-027997
ffd NetFeeAmt NetFeeAmt USD 212.33 2026-09-25 S-8 2026-09-28 0001437749-26-031367
ffd TtlFeeAmt TtlFeeAmt USD 212.33 2026-09-25 S-8 2026-09-28 0001437749-26-031367
ffd TtlOfferingAmt TtlOfferingAmt USD 1.54M 2026-09-25 S-8 2026-09-28 0001437749-26-031367
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-09-25 S-8 2026-09-28 0001437749-26-031367
us-gaap AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent Accounts Payable and Accrued Liabilities USD 2.70M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001437749-26-035280
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 886,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001437749-26-035280
us-gaap AccountsPayableTradeCurrentAndNoncurrent Accounts Payable, Trade USD 886,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001437749-26-035280
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD -35,000 2003-01-01 2012-09-30 2012 Q3 10-Q 2012-11-13 0001193125-12-467372
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 1.81M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001437749-26-035280
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 39,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001437749-26-035280
us-gaap AccruedProfessionalFeesCurrentAndNoncurrent Accrued Professional Fees USD 133,000 2026-03-31 2026 Q1 10-Q 2026-05-07 0001437749-26-015604
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 228,000 2025-12-31 2025 FY 10-K 2026-03-05 0001437749-26-007078
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 175.97M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001437749-26-035280
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 11.01M 2012-06-30 2012 Q2 10-Q 2012-08-14 0001193125-12-355540
us-gaap AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation Share-based Payment Arrangement, Decrease for Tax Withholding Obligation USD 107,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001437749-26-035280
us-gaap AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings Adjustments to Additional Paid in Capital, Dividends in Excess of Retained Earnings USD -209,000 2015-01-01 2015-12-31 2016 FY 10-K 2017-03-30 0001193125-17-102730
us-gaap AdjustmentsToAdditionalPaidInCapitalOther Adjustments to Additional Paid in Capital, Other USD 699,000 2012-01-01 2012-12-31 2013 FY 10-K 2014-03-28 0001193125-14-121519
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, ESPP, Increase for Cost Recognition USD 13,000 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-08-12 0001193125-15-287233
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 285,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001437749-26-035280
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD 491,000 2014-01-01 2014-03-31 2014 Q1 10-Q 2014-05-14 0001193125-14-198000
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 435,000 2025-07-01 2025-09-30 2026 Q3 10-Q 2026-11-05 0001437749-26-035280
us-gaap AdjustmentsToAdditionalPaidInCapitalStockSplit Adjustments to Additional Paid in Capital, Stock Split USD 1,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-05 0001437749-26-007078
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 13,000 2012-01-01 2012-12-31 2013 FY 10-K 2014-03-28 0001193125-14-121519
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 881,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001437749-26-035280
us-gaap AmortizationOfLeasedAsset Amortization of Leased Asset USD 9,000 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-28 0001193125-14-121519
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 14.45M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001437749-26-035280
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-27 0001683168-19-000795
us-gaap Assets Assets USD 11.32M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001437749-26-035280
us-gaap AssetsCurrent Assets, Current USD 11.31M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001437749-26-035280
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 16.05M 2013-06-30 2013 Q2 10-Q 2013-08-14 0001193125-13-333766
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 0 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-13 0001683168-21-001971
us-gaap CapitalLeasedAssetsGross Capital Leased Assets, Gross USD 26,000 2013-12-31 2013 FY 10-K 2014-03-28 0001193125-14-121519
us-gaap CapitalLeaseObligations Capital Lease Obligations USD 0 2013-12-31 2013 FY 10-K 2014-03-28 0001193125-14-121519
us-gaap CapitalLeaseObligationsCurrent Capital Lease Obligations, Current USD 5,000 2012-12-31 2013 FY 10-K 2014-03-28 0001193125-14-121519
us-gaap CapitalLeaseObligationsIncurred Lease Obligation Incurred USD 620,000 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-26 0001683168-20-000969
us-gaap CapitalLeaseObligationsNoncurrent Capital Lease Obligations, Noncurrent USD 5,000 2011-12-31 2012 FY 10-K 2013-03-29 0001193125-13-133515
us-gaap CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation Capital Leases, Lessee Balance Sheet, Assets by Major Class, Accumulated Depreciation USD 26,000 2013-12-31 2013 FY 10-K 2014-03-28 0001193125-14-121519
us-gaap Cash Cash USD 6.47M 2024-03-31 2024 Q1 10-Q 2024-05-09 0001683168-24-003175
us-gaap CashAcquiredFromAcquisition Cash Acquired from Acquisition USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-27 0001683168-19-000795
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 10.61M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001437749-26-035280
us-gaap CashAndCashEquivalentsFairValueDisclosure Cash and Cash Equivalents, Fair Value Disclosure USD 5.39M 2024-09-30 2024 Q3 10-Q 2024-11-14 0001683168-24-008120
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD 7.79M 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-30 0001193125-17-102730
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 10.78M 2025-06-30 2025 Q2 10-Q 2025-08-14 0001683168-25-006174
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 10.61M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001437749-26-035280
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD 5.39M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-14 0001683168-25-006174
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -10.42M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001437749-26-035280
us-gaap CashFDICInsuredAmount Cash, FDIC Insured Amount USD 250,000 2024-12-31 2024 FY 10-K 2025-03-31 0001683168-25-002134
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 2.3 2026-09-30 2026 Q3 10-Q 2026-11-05 0001437749-26-035280
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 13.36M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001437749-26-035280
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 801.36M 2012-12-31 2012 FY 10-K 2013-03-29 0001193125-13-133515
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001437749-26-035280
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 100.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001437749-26-035280
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 11.95M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001437749-26-035280
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 11.95M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001437749-26-035280
us-gaap CommonStockValue Common Stock, Value, Issued USD 1,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001437749-26-035280
us-gaap ContractualObligation Contractual Obligation USD 400,000 2025-12-31 2025 FY 10-K 2026-03-05 0001437749-26-007078
us-gaap ContractualObligationDueAfterFifthYear Contractual Obligation, to be Paid, after Year Five USD 100,000 2023-12-31 2023 FY 10-K 2024-04-01 0001683168-24-002021
us-gaap ContractualObligationDueInFifthYear Contractual Obligation, to be Paid, Year Five USD 100,000 2024-12-31 2024 FY 10-K 2025-03-31 0001683168-25-002134
us-gaap ContractualObligationDueInFourthYear Contractual Obligation, to be Paid, Year Four USD 100,000 2025-12-31 2025 FY 10-K 2026-03-05 0001437749-26-007078
us-gaap ContractualObligationDueInNextTwelveMonths Contractual Obligation, to be Paid, Year One USD 100,000 2025-12-31 2025 FY 10-K 2026-03-05 0001437749-26-007078
us-gaap ContractualObligationDueInSecondYear Contractual Obligation, to be Paid, Year Two USD 100,000 2025-12-31 2025 FY 10-K 2026-03-05 0001437749-26-007078
us-gaap ContractualObligationDueInThirdYear Contractual Obligation, to be Paid, Year Three USD 100,000 2025-12-31 2025 FY 10-K 2026-03-05 0001437749-26-007078
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 3.52M 2017-01-01 2017-03-31 2018 Q1 10-Q 2018-05-10 0001193125-18-158327
us-gaap ConvertibleLongTermNotesPayable Convertible Notes Payable, Noncurrent USD 500,000 2011-12-31 2012 FY 10-K 2013-03-29 0001193125-13-133515
us-gaap ConvertiblePreferredStockSharesIssuedUponConversion Convertible Preferred Stock, Shares Issued upon Conversion shares 1,111.11 2016-12-21 2016 FY 10-K 2017-03-30 0001193125-17-102730
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001437749-26-007078
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001437749-26-007078
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001437749-26-007078
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 1.00M 2012-01-01 2012-12-31 2013 FY 10-K 2014-03-28 0001193125-14-121519
us-gaap DebtConversionConvertedInstrumentSharesIssued1 Debt Conversion, Converted Instrument, Shares Issued shares 9,500 2012-04-01 2012-04-27 2012 FY 10-K 2013-03-29 0001193125-13-133515
us-gaap DebtConversionOriginalDebtAmount1 Debt Conversion, Original Debt, Amount USD 1.00M 2012-04-01 2012-04-27 2012 FY 10-K 2013-03-29 0001193125-13-133515
us-gaap DebtInstrumentConvertibleConversionPrice1 Debt Instrument, Convertible, Conversion Price USD/shares 1,000 2011-09-24 2012 FY 10-K 2013-03-29 0001193125-13-133515
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD 2.25M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001437749-26-007078
us-gaap DeferredFederalStateAndLocalTaxExpenseBenefit Deferred Federal, State and Local, Tax Expense (Benefit) USD 2.61M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001437749-26-007078
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-27 0001683168-19-000795
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 17,000 2025-12-31 2025 FY 10-K 2026-03-05 0001437749-26-007078
us-gaap DeferredRevenue Deferred Revenue USD 27,000 2012-12-31 2013 FY 10-K 2014-03-28 0001193125-14-121519
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 47,000 2014-12-31 2015 FY 10-K 2016-03-30 0001193125-16-523721
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD 358,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001437749-26-007078
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 3,000 2024-12-31 2024 FY 10-K 2025-03-31 0001683168-25-002134
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 2.63M 2025-12-31 2025 FY 10-K 2026-03-05 0001437749-26-007078
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-05 0001437749-26-007078
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 1.99M 2025-12-31 2025 FY 10-K 2026-03-05 0001437749-26-007078
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 98,000 2025-12-31 2025 FY 10-K 2026-03-05 0001437749-26-007078
us-gaap DeferredTaxAssetsTaxCreditCarryforwards Deferred Tax Assets, Tax Credit Carryforwards USD 212,000 2025-12-31 2025 FY 10-K 2026-03-05 0001437749-26-007078
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 248,000 2025-12-31 2025 FY 10-K 2026-03-05 0001437749-26-007078
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 84,000 2025-12-31 2025 FY 10-K 2026-03-05 0001437749-26-007078
us-gaap DeferredTaxAssetsTaxDeferredExpenseOther Deferred Tax Assets, Tax Deferred Expense, Other USD 2,000 2019-12-31 2019 FY 10-K 2020-03-26 0001683168-20-000969
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 2.61M 2025-12-31 2025 FY 10-K 2026-03-05 0001437749-26-007078
us-gaap DeferredTaxLiabilitiesLeasingArrangements Deferred Tax Liabilities, Leasing Arrangements USD 0 2025-12-31 2025 FY 10-K 2026-03-05 0001437749-26-007078
us-gaap DeferredTaxLiabilitiesOther Deferred Tax Liabilities, Other USD 17,000 2025-12-31 2025 FY 10-K 2026-03-05 0001437749-26-007078
us-gaap DepositsAssetsNoncurrent Deposits Assets, Noncurrent USD 18,000 2014-03-31 2014 Q1 10-Q 2014-05-14 0001193125-14-198000
us-gaap Depreciation Depreciation USD 2,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001683168-25-002134
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 75.00M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-22 0001683168-22-001833
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 4,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001437749-26-035280
us-gaap DerivativeFairValueOfDerivativeLiability Derivative Liability, Fair Value, Gross Liability USD 8.72M 2011-09-24 2012 FY 10-K 2013-03-29 0001193125-13-133515
us-gaap DerivativeLiabilityFairValueNet1 Derivative Liability, Fair Value, Net (Deprecated 2013-01-31) USD 3.14M 2010-12-31 2012 FY 10-K 2013-03-29 0001193125-13-133515
us-gaap DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) USD 40.37M 2014-03-31 2014 Q1 10-Q 2014-05-14 0001193125-14-198000
us-gaap DividendsPreferredStock Dividends, Preferred Stock USD 126,000 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-30 0001193125-16-523721
us-gaap DividendsPreferredStockPaidinkind Dividends, Preferred Stock, Paid-in-kind USD 104,000 2015-01-01 2015-12-31 2016 FY 10-K 2017-03-30 0001193125-17-102730
us-gaap DividendsPreferredStockStock Dividends, Preferred Stock, Stock USD -6.90M 2013-01-01 2013-09-30 2013 Q3 10-Q 2013-11-14 0001193125-13-441091
us-gaap DueFromAffiliateCurrent Due from Affiliate, Current USD 597,000 2011-12-31 2012 FY 10-K 2013-03-29 0001193125-13-133515
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -1.06 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001437749-26-035280
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -1.04 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-22 0001683168-22-001833
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.86 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-14 0001683168-25-006174
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001437749-26-007078
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001437749-26-007078
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.229 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001437749-26-007078
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-27 0001683168-19-000795
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent pure -0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001437749-26-007078
us-gaap EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent pure -0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001437749-26-007078
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.106 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-05 0001437749-26-007078
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure -0.021 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001437749-26-007078
us-gaap EmployeeBenefitsAndShareBasedCompensation Employee Benefits and Share-based Compensation USD 99,000 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-15 0001683168-25-003719
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 31,000 2024-12-31 2024 FY 10-K 2025-03-31 0001683168-25-002134
us-gaap EmployeeRelatedLiabilitiesCurrentAndNoncurrent Employee-related Liabilities USD 422,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001437749-26-035280
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 157,000 2017-12-31 2017 FY 10-K 2018-03-26 0001193125-18-096053
us-gaap EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense Share-based Payment Arrangement, Expense, Tax Benefit USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-26 0001193125-18-096053
us-gaap FairValueAssetsLevel1ToLevel2TransfersAmount Fair Value, Assets, Level 1 to Level 2 Transfers, Amount USD 0 2016-12-31 2016 FY 10-K 2017-03-30 0001193125-17-102730
us-gaap FairValueAssetsLevel2ToLevel1TransfersAmount Fair Value, Assets, Level 2 to Level 1 Transfers, Amount USD 0 2015-12-31 2016 FY 10-K 2017-03-30 0001193125-17-102730
us-gaap FairValueOfAssetsAcquired Fair Value of Assets Acquired USD 2.74M 2017-01-01 2017-03-31 2018 Q1 10-Q 2018-05-10 0001193125-18-158327
us-gaap FurnitureAndFixturesGross Furniture and Fixtures, Gross USD 8,000 2024-12-31 2024 FY 10-K 2025-03-31 0001683168-25-002134
us-gaap GainLossOnDispositionOfAssets Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property USD 6,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001683168-25-002134
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD 3,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001437749-26-035280
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-22 0001683168-23-001678
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 3.77M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001437749-26-035280
us-gaap GrantsReceivable Grants Receivable USD 800,000 2012-12-31 2012 FY 10-K 2013-03-29 0001193125-13-133515
us-gaap HeldToMaturitySecuritiesCurrent Debt Securities, Held-to-maturity, Current USD 5.50M 2015-12-31 2016 FY 10-K 2017-03-30 0001193125-17-102730
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001683168-25-002134
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -11.48M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-22 0001683168-23-001678
us-gaap IncomeTaxExaminationPenaltiesAndInterestAccrued Income Tax Examination, Penalties and Interest Accrued USD 0 2025-12-31 2025 FY 10-K 2026-03-05 0001437749-26-007078
us-gaap IncomeTaxExaminationPenaltiesAndInterestExpense Income Tax Examination, Penalties and Interest Expense USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001683168-25-002134
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001437749-26-007078
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 1.99M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001437749-26-007078
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -1.83M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001437749-26-007078
us-gaap IncomeTaxReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount USD 10,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001437749-26-007078
us-gaap IncomeTaxReconciliationOtherReconcilingItems Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount USD 3,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001437749-26-007078
us-gaap IncomeTaxReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Amount USD 179,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001437749-26-007078
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 451,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001437749-26-035280
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 906,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001437749-26-035280
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD -47,000 2015-01-01 2015-12-31 2016 FY 10-K 2017-03-30 0001193125-17-102730
us-gaap IncreaseDecreaseInDerivativeAssetsAndLiabilities Increase (Decrease) in Derivative Assets and Liabilities USD -2.61M 2011-01-01 2011-09-24 2012 FY 10-K 2013-03-29 0001193125-13-133515
us-gaap IncreaseDecreaseInDueToOtherRelatedPartiesCurrent Increase (Decrease) in Due to Other Related Parties, Current USD 597,000 2012-01-01 2012-12-31 2013 FY 10-K 2014-03-28 0001193125-14-121519
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001437749-26-007078
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 256,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001437749-26-035280
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD -46,000 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-05-12 0001193125-16-588016
us-gaap IncreaseDecreaseInRestrictedCash Increase (Decrease) in Restricted Cash USD -3,000 2013-01-01 2013-12-31 2014 FY 10-K 2015-03-30 0001193125-15-110334
us-gaap InterestAndOtherIncome Interest and Other Income USD 6,000 2014-01-01 2014-03-31 2014 Q1 10-Q 2014-05-14 0001193125-14-198000
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD -125,000 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-15 0001683168-25-003719
us-gaap InterestIncomeExpenseNet Interest Income (Expense), Net USD 231,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001683168-25-002134
us-gaap InterestIncomeExpenseNonoperatingNet Interest Income (Expense), Nonoperating, Net USD -9,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-22 0001683168-22-001833
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 3,000 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-27 0001683168-19-000795
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001437749-26-007078
us-gaap InvestmentIncomeNet Investment Income, Net USD 395,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001437749-26-035280
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 71,000 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-13 0001193125-14-410208
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 115,000 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-26 0001193125-18-096053
us-gaap LeaseCost Lease, Cost USD 102,000 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-26 0001683168-20-000969
us-gaap LeaseholdImprovementsGross Leasehold Improvements, Gross USD 0 2024-12-31 2024 FY 10-K 2025-03-31 0001683168-25-002134
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 35,000 2023-12-31 2023 FY 10-K 2024-04-01 0001683168-24-002021
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 35,000 2019-09-30 2019 Q3 10-Q 2019-11-12 0001683168-19-003526
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 35,000 2023-12-31 2023 FY 10-K 2024-04-01 0001683168-24-002021
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 35,000 2020-09-30 2020 Q3 10-Q 2020-11-10 0001683168-20-003809
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 35,000 2020-12-31 2020 FY 10-K 2021-03-25 0001683168-21-001062
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 35,000 2022-03-31 2022 Q1 10-Q 2022-05-12 0001683168-22-003516
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 35,000 2022-12-31 2022 FY 10-K 2023-03-22 0001683168-23-001678
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 36,000 2023-09-30 2023 Q3 10-Q 2023-11-09 0001683168-23-007809
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 0 2023-12-31 2023 FY 10-K 2024-04-01 0001683168-24-002021
us-gaap Liabilities Liabilities USD 2.70M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001437749-26-035280
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 11.32M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001437749-26-035280
us-gaap LiabilitiesCurrent Liabilities, Current USD 1.21M 2025-06-30 2025 Q2 10-Q 2025-08-14 0001683168-25-006174
us-gaap LiabilityForUncertainTaxPositionsCurrent Liability for Uncertainty in Income Taxes, Current USD 0 2025-12-31 2025 FY 10-K 2026-03-05 0001437749-26-007078
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 0 2021-12-31 2021 FY 10-K 2022-03-22 0001683168-22-001833
us-gaap LossContingencyAccrualAtCarryingValue Loss Contingency Accrual USD 0 2025-12-31 2025 FY 10-K 2026-03-05 0001437749-26-007078
us-gaap LossContingencyLossInPeriod Loss Contingency, Loss in Period USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001683168-25-002134
us-gaap MachineryAndEquipmentGross Machinery and Equipment, Gross USD 265,000 2024-12-31 2024 FY 10-K 2025-03-31 0001683168-25-002134
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD -107,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001437749-26-035280
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 932,000 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-10 0001193125-18-158327
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 3,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001437749-26-035280
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD 98,000 2017-01-01 2017-03-31 2018 Q1 10-Q 2018-05-10 0001193125-18-158327
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -10.32M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001437749-26-035280
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -1.91M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-10 0001193125-18-158327
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -12.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001437749-26-035280
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -12.45M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-26 0001193125-18-096053
us-gaap NoncashOrPartNoncashAcquisitionPayablesAssumed1 Noncash or Part Noncash Acquisition, Payables Assumed USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-27 0001683168-19-000795
us-gaap NoninterestExpenseOfferingCost Noninterest Expense Offering Cost USD 1.28M 2025-01-01 2025-03-31 2025 Q2 10-Q 2025-08-14 0001683168-25-006174
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 246,000 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-14 0001683168-25-006174
us-gaap NotesAndLoansReceivableNetNoncurrent Financing Receivable, after Allowance for Credit Loss, Noncurrent USD 150,000 2016-12-31 2017 Q1 10-Q/A 2018-03-26 0001193125-18-095994
us-gaap NotesReduction Notes Reduction USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-27 0001683168-19-000795
us-gaap NumberOfOperatingSegments Number of Operating Segments pure 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001437749-26-035280
us-gaap NumberOfReportableSegments Number of Reportable Segments pure 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001437749-26-035280
us-gaap OperatingExpenses Operating Expenses USD 12.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001437749-26-035280
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -12.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001437749-26-035280
us-gaap OperatingLeaseCost Operating Lease, Cost USD 16,800 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-14 0001683168-25-006174
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 2,700 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001437749-26-035280
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 0 2024-12-31 2024 FY 10-K 2025-03-31 0001683168-25-002134
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 0 2024-12-31 2024 FY 10-K 2025-03-31 0001683168-25-002134
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 0 2024-12-31 2024 FY 10-K 2025-03-31 0001683168-25-002134
us-gaap OperatingLeasePayments Operating Lease, Payments USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001437749-26-035280
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 0 2024-12-31 2024 FY 10-K 2025-03-31 0001683168-25-002134
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001437749-26-007078
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 30,000 2018-12-31 2018 FY 10-K 2019-03-27 0001683168-19-000795
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 30,000 2018-12-31 2018 FY 10-K 2019-03-27 0001683168-19-000795
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 30,000 2014-12-31 2014 FY 10-K 2015-03-30 0001193125-15-110334
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 30,000 2015-12-31 2015 FY 10-K 2016-03-30 0001193125-16-523721
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 30,000 2016-12-31 2016 FY 10-K 2017-03-30 0001193125-17-102730
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 30,000 2017-12-31 2017 FY 10-K 2018-03-26 0001193125-18-096053
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 0 2014-12-31 2014 FY 10-K 2015-03-30 0001193125-15-110334
us-gaap OperatingLeasesFutureMinimumPaymentsReceivable Operating Leases, Future Minimum Payments Receivable USD 70,000 2012-12-31 2012 FY 10-K 2013-03-29 0001193125-13-133515
us-gaap OperatingLeasesFutureMinimumPaymentsReceivableCurrent Operating Leases, Future Minimum Payments Receivable, Current USD 57,000 2012-12-31 2012 FY 10-K 2013-03-29 0001193125-13-133515
us-gaap OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears Operating Leases, Future Minimum Payments Receivable, in Two Years USD 13,000 2012-12-31 2012 FY 10-K 2013-03-29 0001193125-13-133515
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 127,000 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-26 0001683168-20-000969
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0 2024-12-31 2024 FY 10-K 2025-03-31 0001683168-25-002134
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 46.80M 2014-12-31 2014 FY 10-K 2015-03-30 0001193125-15-110334
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 17,000 2024-12-31 2024 FY 10-K 2025-03-31 0001683168-25-002134
us-gaap OtherAssets Other Assets USD 2,000 2012-09-30 2012 Q3 10-Q 2012-11-13 0001193125-12-467372
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 0 2024-12-31 2024 FY 10-K 2025-03-31 0001683168-25-002134
us-gaap OtherGeneralAndAdministrativeExpense Other General and Administrative Expense USD 473,000 2013-01-01 2013-03-31 2013 Q1 10-Q 2013-05-15 0001193125-13-220846
us-gaap OtherIncome Other Income USD 6,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001683168-25-002134
us-gaap OtherNoncashExpense Other Noncash Expense USD 109,000 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-26 0001683168-20-000969
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 7,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001437749-26-035280
us-gaap OtherResearchAndDevelopmentExpense Other Research and Development Expense USD 0 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-10 0001683168-22-007528
us-gaap PaymentOfFinancingAndStockIssuanceCosts Payment of Financing and Stock Issuance Costs USD 52,000 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-12 0001683168-19-003526
us-gaap PaymentsForProceedsFromOtherInvestingActivities Payments for (Proceeds from) Other Investing Activities USD 18,000 2013-01-01 2013-12-31 2014 FY 10-K 2015-03-30 0001193125-15-110334
us-gaap PaymentsForRent Payments for Rent USD 10,300 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-27 0001683168-19-000795
us-gaap PaymentsForRepurchaseOfRedeemablePreferredStock Payments for Repurchase of Redeemable Preferred Stock USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001683168-25-002134
us-gaap PaymentsOfCapitalDistribution Payments of Capital Distribution USD 12,000 2013-01-01 2013-12-31 2014 FY 10-K 2015-03-30 0001193125-15-110334
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 0 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-10 0001683168-20-003809
us-gaap PaymentsRelatedToTaxWithholdingForShareBasedCompensation Payment, Tax Withholding, Share-based Payment Arrangement USD 107,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001437749-26-035280
us-gaap PaymentsToAcquireBusinessesNetOfCashAcquired Payments to Acquire Businesses, Net of Cash Acquired USD -100,000 2017-01-01 2017-03-31 2017 Q1 10-Q/A 2018-03-26 0001193125-18-095994
us-gaap PaymentsToAcquireNotesReceivable Payments to Acquire Notes Receivable USD 150,000 2016-01-01 2016-12-31 2017 FY 10-K 2018-03-26 0001193125-18-096053
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001437749-26-035280
us-gaap PaymentsToAcquireShortTermInvestments Payments to Acquire Short-term Investments USD 2.00M 2016-01-01 2016-12-31 2017 FY 10-K 2018-03-26 0001193125-18-096053
us-gaap PreferredStockConversionsInducements Preferred Stock Conversions, Inducements USD 4.00M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001683168-25-002134
us-gaap PreferredStockDividendsAndOtherAdjustments Preferred Stock Dividends and Other Adjustments USD 3.67M 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-13 0001193125-14-410208
us-gaap PreferredStockDividendsIncomeStatementImpact Preferred Stock Dividends, Income Statement Impact USD 2.08M 2016-01-01 2016-12-31 2017 FY 10-K 2018-03-26 0001193125-18-096053
us-gaap PreferredStockLiquidationPreferenceValue Preferred Stock, Liquidation Preference, Value USD 0 2013-12-31 2013 FY 10-K 2014-03-28 0001193125-14-121519
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001437749-26-035280
us-gaap PreferredStockRedemptionDiscount Preferred Stock Redemption Discount USD 9.50M 2012-01-01 2012-12-31 2013 FY 10-K 2014-03-28 0001193125-14-121519
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001437749-26-035280
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001437749-26-035280
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001437749-26-035280
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001437749-26-035280
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 701,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001437749-26-035280
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 843,000 2022-09-30 2022 Q3 10-Q 2022-11-10 0001683168-22-007528
us-gaap ProceedsFromContributionsFromParent Proceeds from Contributions from Parent USD 699,000 2012-01-01 2012-12-31 2013 FY 10-K 2014-03-28 0001193125-14-121519
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 500,000 2012-01-01 2012-12-31 2013 FY 10-K 2014-03-28 0001193125-14-121519
us-gaap ProceedsFromInterestReceived Proceeds from Interest Received USD 724,000 2003-01-01 2012-09-30 2012 Q3 10-Q 2012-11-13 0001193125-12-467372
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 0 2019-01-01 2019-03-31 2019 Q1 10-Q 2019-05-14 0001683168-19-001519
us-gaap ProceedsFromIssuanceOfConvertiblePreferredStock Proceeds from Issuance of Convertible Preferred Stock USD 8.50M 2012-01-01 2012-12-31 2013 FY 10-K 2014-03-28 0001193125-14-121519
us-gaap ProceedsFromIssuanceOfDebt Proceeds from Issuance of Debt USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-22 0001683168-22-001833
us-gaap ProceedsFromIssuanceOfRedeemablePreferredStock Proceeds from Issuance of Redeemable Preferred Stock USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-01 0001683168-24-002021
us-gaap ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised USD 1,000 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-25 0001683168-21-001062
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 20.60M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001437749-26-007078
us-gaap ProceedsFromOtherEquity Proceeds from Other Equity USD 6.49M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-14 0001683168-25-006174
us-gaap ProceedsFromPaymentsForOtherFinancingActivities Proceeds from (Payments for) Other Financing Activities USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-22 0001683168-22-001833
us-gaap ProceedsFromSaleMaturityAndCollectionsOfInvestments Proceeds from Sale, Maturity and Collection of Investments USD 7.50M 2016-01-01 2016-12-31 2017 FY 10-K 2018-03-26 0001193125-18-096053
us-gaap ProceedsFromSaleOfOtherProductiveAssets Proceeds from Sale of Other Productive Assets USD 9,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001683168-25-002134
us-gaap ProceedsFromSaleOfProductiveAssets Proceeds from Sale of Productive Assets USD 3,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001437749-26-035280
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 12,000 2014-01-01 2014-12-31 2015 FY 10-K 2016-03-30 0001193125-16-523721
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 5,000 2013-01-01 2013-12-31 2014 FY 10-K 2015-03-30 0001193125-15-110334
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001437749-26-035280
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 239,000 2025-12-31 2025 FY 10-K 2026-03-05 0001437749-26-007078
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 7,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001437749-26-035280
us-gaap PropertyPlantAndEquipmentOther Property, Plant and Equipment, Other, Gross USD 35,000 2024-12-31 2024 FY 10-K 2025-03-31 0001683168-25-002134
us-gaap PropertyPlantAndEquipmentOwnedAccumulatedDepreciation Property, Plant, and Equipment, Owned, Accumulated Depreciation USD 585,000 2012-12-31 2012 FY 10-K 2013-03-29 0001193125-13-133515
us-gaap PropertyPlantAndEquipmentTransfersAndChanges Property, Plant and Equipment, Transfers and Changes USD 126,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-01 0001683168-24-002021
us-gaap ReclassificationsOfTemporaryToPermanentEquity Reclassifications of Temporary to Permanent Equity USD 2.00M 2015-01-01 2015-12-31 2016 FY 10-K 2017-03-30 0001193125-17-102730
us-gaap RepaymentsOfDebtAndCapitalLeaseObligations Repayments of Debt and Lease Obligation USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-22 0001683168-22-001833
us-gaap RepaymentsOfLongTermCapitalLeaseObligations Repayments of Long-term Capital Lease Obligations USD 5,000 2013-01-01 2013-12-31 2014 FY 10-K 2015-03-30 0001193125-15-110334
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 6,000 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-26 0001683168-20-000969
us-gaap ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff Research and Development Asset Acquired Other than Through Business Combination, Written-off USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-27 0001683168-19-000795
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 8.94M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001437749-26-035280
us-gaap ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost Research and Development Expense (Excluding Acquired in Process Cost) USD 1.10M 2013-01-01 2013-03-31 2013 Q1 10-Q 2013-05-15 0001193125-13-220846
us-gaap RestrictedCash Restricted Cash USD 0 2024-09-30 2024 Q3 10-Q 2024-11-14 0001683168-24-008120
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 50,000 2017-12-31 2017 FY 10-K 2018-03-26 0001193125-18-096053
us-gaap RestrictedCashAndCashEquivalentsAtCarryingValue Restricted Cash and Cash Equivalents, Current USD 50,000 2018-03-31 2018 Q1 10-Q 2018-05-10 0001193125-18-158327
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -167.35M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001437749-26-035280
us-gaap RevenueFromGrants Revenue from Grants (Deprecated 2018-01-31) USD 34,000 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-30 0001193125-16-523721
us-gaap Revenues Revenues USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-25 0001683168-21-001062
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-25 0001683168-21-001062
us-gaap SalesRevenueNet Revenue, Net (Deprecated 2018-01-31) USD 57,000 2003-01-01 2012-09-30 2012 Q3 10-Q 2012-11-13 0001193125-12-467372
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 881,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001437749-26-035280
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 2.04 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-28 0001193125-14-121519
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001683168-25-002134
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 1.137 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001683168-25-002134
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum pure 0.915 2018-01-01 2018-03-31 2019 Q1 10-Q 2019-05-14 0001683168-19-001519
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum pure 0.913 2018-01-01 2018-03-31 2019 Q1 10-Q 2019-05-14 0001683168-19-001519
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.047 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001683168-25-002134
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum pure 0.028 2018-01-01 2018-03-31 2019 Q1 10-Q 2019-05-14 0001683168-19-001519
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum pure 0.027 2018-01-01 2018-03-31 2019 Q1 10-Q 2019-05-14 0001683168-19-001519
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate pure 0.989 2019-01-01 2019-03-31 2019 Q1 10-Q 2019-05-14 0001683168-19-001519
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized shares 750,000 2018-12-31 2018 FY 10-K 2019-03-27 0001683168-19-000795
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant shares 470,803 2018-12-31 2018 FY 10-K 2019-03-27 0001683168-19-000795
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 0 2025-09-30 2025 Q3 10-Q 2025-11-13 0001437749-25-034857
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 1,121 2025-12-31 2025 FY 10-K 2026-03-05 0001437749-26-007078
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 614.6 2025-12-31 2025 FY 10-K 2026-03-05 0001437749-26-007078
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 0 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-30 0001193125-15-110334
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 5 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001437749-26-007078
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001437749-26-007078
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures shares 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001437749-26-007078
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 0 2025-01-01 2025-06-30 2026 Q2 10-Q 2026-08-06 0001437749-26-026271
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 1.14 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-31 0001683168-25-002134
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 0 2025-09-30 2025 Q3 10-Q 2025-11-13 0001437749-25-034857
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 1,121 2025-12-31 2025 FY 10-K 2026-03-05 0001437749-26-007078
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 614.6 2025-12-31 2025 FY 10-K 2026-03-05 0001437749-26-007078
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost Share-based Payment Arrangement, Plan Modification, Incremental Cost USD 22,000 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-26 0001193125-18-096053
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001437749-26-007078
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 133,863.84 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001437749-26-007078
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001437749-26-007078
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001437749-26-007078
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit USD/shares 0.65 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-28 0001193125-14-121519
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit USD/shares 7.5 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-28 0001193125-14-121519
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 0.4 2015-06-02 2015 FY 10-K 2016-03-30 0001193125-16-523721
us-gaap ShortTermInvestments Short-term Investments USD 8.00M 2015-09-30 2015 Q3 10-Q 2015-11-12 0001193125-15-375630
us-gaap StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants USD 7.06M 2016-01-01 2016-12-31 2017 FY 10-K 2018-03-26 0001193125-18-096053
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 8.62M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001437749-26-035280
us-gaap StockholdersEquityNoteStockSplitConversionRatio Stockholders' Equity Note, Stock Split, Conversion Ratio (Deprecated 2013-01-31) Ratio 1.00M 2012-04-01 2012-04-26 2012 FY 10-K 2013-03-29 0001193125-13-133515
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.018 2020-01-01 2020-03-31 2020 Q2 10-Q 2020-08-12 0001683168-20-002649
us-gaap StockIssued1 Stock Issued USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-27 0001683168-19-000795
us-gaap StockIssuedDuringPeriodSharesAcquisitions Stock Issued During Period, Shares, Acquisitions shares 1.67M 2013-03-11 2013-03-12 2013 FY 10-K 2014-03-28 0001193125-14-121519
us-gaap StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities Stock Issued During Period, Shares, Conversion of Convertible Securities shares 0 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-10 0001193125-18-158327
us-gaap StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans Stock Issued During Period, Shares, Employee Stock Purchase Plans shares 1 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-26 0001683168-20-000969
us-gaap StockIssuedDuringPeriodSharesIssuedForCash Development Stage Entities, Stock Issued, Shares, Issued for Cash (Deprecated 2015-01-31) shares 100 2011-08-09 2011-09-08 2013 Q2 10-Q 2013-08-14 0001193125-13-333766
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 3.77M 2013-03-05 2013-03-06 2013 FY 10-K 2014-03-28 0001193125-14-121519
us-gaap StockIssuedDuringPeriodSharesPurchaseOfAssets Stock Issued During Period, Shares, Purchase of Assets shares 275,036 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-26 0001193125-18-096053
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001437749-26-007078
us-gaap StockIssuedDuringPeriodSharesStockSplits Stock Issued During Period, Shares, Stock Splits shares 66.96M 2012-04-01 2012-04-26 2012 FY 10-K 2013-03-29 0001193125-13-133515
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 12.25M 2013-01-01 2013-12-31 2014 FY 10-K 2015-03-30 0001193125-15-110334
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 40,000 2025-04-01 2025-06-30 2025 Q2 10-Q 2025-08-14 0001683168-25-006174
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments Stock Issued During Period, Value, Conversion of Convertible Securities, Net of Adjustments USD 208,000 2012-01-01 2012-09-30 2012 Q3 10-Q 2012-11-13 0001193125-12-467372
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 1,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-22 0001683168-22-001833
us-gaap StockIssuedDuringPeriodValueIssuedForNoncashConsiderations Development Stage Entities, Stock Issued, Value, Issued for Noncash Consideration (Deprecated 2015-01-31) USD 1 2011-08-09 2011-09-08 2013 Q2 10-Q 2013-08-14 0001193125-13-333766
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 6.49M 2025-01-01 2025-03-31 2025 Q2 10-Q 2025-08-14 0001683168-25-006174
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD -58,000 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-25 0001683168-21-001062
us-gaap StockIssuedDuringPeriodValuePurchaseOfAssets Stock Issued During Period, Value, Purchase of Assets USD 2.82M 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-27 0001683168-19-000795
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardGross Stock Issued During Period, Value, Restricted Stock Award, Gross USD 0 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001437749-26-035280
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures USD 0 2023-07-01 2023-09-30 2023 Q3 10-Q 2023-11-09 0001683168-23-007809
us-gaap StockIssuedDuringPeriodValueStockDividend Stock Issued During Period, Value, Stock Dividend USD 5.95M 2013-01-01 2013-06-30 2013 Q2 10-Q 2013-08-14 0001193125-13-333766
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 5,000 2013-01-01 2013-12-31 2014 FY 10-K 2015-03-30 0001193125-15-110334
us-gaap TemporaryEquityAccretionToRedemptionValue Temporary Equity, Accretion to Redemption Value USD -9.50M 2012-01-01 2012-12-31 2013 FY 10-K 2014-03-28 0001193125-14-121519
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 0 2024-12-31 2024 FY 10-K 2025-03-31 0001683168-25-002134
us-gaap TemporaryEquityLiquidationPreference Temporary Equity, Liquidation Preference USD 9.90M 2013-03-31 2013 Q1 10-Q 2013-05-15 0001193125-13-220846
us-gaap TemporaryEquityParOrStatedValuePerShare Temporary Equity, Par or Stated Value Per Share USD/shares 0 2024-12-31 2024 FY 10-K 2025-03-31 0001683168-25-002134
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 10.00M 2024-12-31 2024 FY 10-K 2025-03-31 0001683168-25-002134
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 0 2024-12-31 2024 FY 10-K 2025-03-31 0001683168-25-002134
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 0 2024-12-31 2024 FY 10-K 2025-03-31 0001683168-25-002134
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2024-12-31 2024 FY 10-K 2025-03-31 0001683168-25-002134
us-gaap ValuationAllowanceAmount Valuation Allowance, Amount (Deprecated 2013-01-31) USD 2.39M 2012-12-31 2012 FY 10-K 2013-03-29 0001193125-13-133515
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 2.61M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001437749-26-007078
us-gaap WeightedAverageNumberDilutedSharesOutstandingAdjustment Weighted Average Number Diluted Shares Outstanding Adjustment shares 0 2014-01-01 2014-06-30 2014 Q2 10-Q 2014-08-14 0001193125-14-309149
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 4.55M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-14 0001683168-25-006174
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 12.83M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-22 0001683168-22-001833
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 11.64M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001437749-26-035280

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →